KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and hip replacement and may protect against renal injury associated with contrast media.
KAI-1455 is a small-molecule biochemical compound recognized for its activity as a selective modulator of protein kinases, particularly those involved in cellular signal transduction pathways. As a structurally defined research tool, KAI-1455 offers significant value in elucidating the mechanisms of kinase-mediated signaling events and their downstream biological effects. Its specificity and potency make it an important resource for investigators seeking to dissect complex cellular processes, understand regulatory networks, and identify new molecular targets in the context of biochemical and molecular biology research.
Signal transduction research: KAI-1455 is extensively utilized in the study of intracellular signaling cascades, particularly those governed by key kinase enzymes. By modulating the activity of specific kinases, researchers can investigate the functional consequences of pathway activation or inhibition, enabling detailed mapping of cellular communication networks. This approach is essential for identifying critical control points in signal transduction and for unraveling the dynamic interplay between different signaling modules within the cell.
Target validation studies: In drug discovery and molecular biology, KAI-1455 serves as a valuable probe for validating the biological relevance of candidate kinases. By selectively inhibiting or modulating kinase function, the compound allows for the assessment of target dependency in various cellular models. This aids in distinguishing primary from secondary effects, confirming the suitability of a kinase as a potential therapeutic or research target, and supporting the rational design of subsequent experimental strategies.
Cellular pathway dissection: The compound is frequently applied in experiments designed to dissect the roles of individual kinases within broader signaling networks. By employing KAI-1455 in combination with genetic or pharmacological interventions, scientists can isolate the contributions of specific enzymes to processes such as cell growth, differentiation, and apoptosis. This mechanistic insight is pivotal for constructing accurate models of cellular regulation and for interpreting phenotypic outcomes in complex biological systems.
High-throughput screening: KAI-1455 is compatible with in vitro kinase assays and high-throughput screening formats, facilitating the identification of novel modulators or interacting partners within the kinase family. Its use in these platforms accelerates the evaluation of compound libraries, supports structure-activity relationship studies, and contributes to the optimization of lead molecules in early-stage research pipelines. The compound's defined activity profile enhances assay fidelity and reproducibility in screening applications.
Chemical biology tool development: Beyond its direct applications in pathway analysis, KAI-1455 serves as a reference molecule in the development and benchmarking of new chemical biology tools. Its well-characterized mode of action provides a standard for comparing the efficacy and selectivity of emerging kinase modulators, as well as for calibrating assay systems. This role is crucial for advancing methodological rigor and for ensuring the reliability of experimental data in kinase-focused research initiatives.
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More